These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dual acting anti-inflammatory drugs: a reappraisal. Bertolini A; Ottani A; Sandrini M Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348 [TBL] [Abstract][Full Text] [Related]
4. New approaches to the modulation of the cyclooxygenase-2 and 5-lipoxygenase pathways. González-Périz A; Clària J Curr Top Med Chem; 2007; 7(3):297-309. PubMed ID: 17305572 [TBL] [Abstract][Full Text] [Related]
5. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Bertolini A; Ottani A; Sandrini M Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982 [TBL] [Abstract][Full Text] [Related]
6. Regulation of inflammation in cancer by eicosanoids. Greene ER; Huang S; Serhan CN; Panigrahy D Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):27-36. PubMed ID: 21864702 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer. Clària J; Romano M Curr Pharm Des; 2005; 11(26):3431-47. PubMed ID: 16250846 [TBL] [Abstract][Full Text] [Related]
8. Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade. Sala A; Proschak E; Steinhilber D; Rovati GE Biochem Pharmacol; 2018 Dec; 158():161-173. PubMed ID: 30315753 [TBL] [Abstract][Full Text] [Related]
9. Activation of diverse eicosanoid pathways in osteoarthritic cartilage: a lipidomic and genomic analysis. Attur M; Dave M; Abramson SB; Amin A Bull NYU Hosp Jt Dis; 2012; 70(2):99-108. PubMed ID: 22891999 [TBL] [Abstract][Full Text] [Related]
10. The acute inflammatory process, arachidonic acid metabolism and the mode of action of anti-inflammatory drugs. Higgins AJ; Lees P Equine Vet J; 1984 May; 16(3):163-75. PubMed ID: 6428879 [TBL] [Abstract][Full Text] [Related]
15. The biology, pathophysiology and control of eicosanoids in inflammation. Higgins AJ J Vet Pharmacol Ther; 1985 Mar; 8(1):1-18. PubMed ID: 2985792 [TBL] [Abstract][Full Text] [Related]
16. Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: role of cyclooxygenase-2. Palumbo S; Bosetti F Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):273-8. PubMed ID: 24095587 [TBL] [Abstract][Full Text] [Related]
17. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response? James MJ; Penglis PS; Caughey GE; Demasi M; Cleland LG Inflamm Res; 2001 May; 50(5):249-53. PubMed ID: 11409487 [TBL] [Abstract][Full Text] [Related]
18. Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation. Colville-Nash PR; Gilroy DW BioDrugs; 2001; 15(1):1-9. PubMed ID: 11437671 [TBL] [Abstract][Full Text] [Related]